Publications by authors named "Jay Cohn"

Claim this Profile
C
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Giuseppe Vergaro, Francesco Gentile, Alberto Aimo, James L Januzzi, A Mark Richards, Jay N Cohn

ESC Heart Fail· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories.
Giuseppe Vergaro, Francesco Gentile, Laura M G Meems, Alberto Aimo, James L Januzzi, Jay N Cohn

JACC Heart Fail· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early cardiovascular structural and functional abnormalities as a guide to future morbid events.
Daniel A Duprez, Sue Duval, Lynn Hoke, Natalia Florea, Gregory Grandits, Jay N Cohn

Eur J Prev Cardiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data.
Nick Marcks, Alberto Aimo, James L Januzzi, Giuseppe Vergaro, Aldo Clerico, Jay N Cohn

Clin Res Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biostatistics Versus Pathophysiology.
Jay N Cohn

Circulation· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
Jay N Cohn

Ann Intern Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, A Mark Richards, Carolyn S P Lam, Jay N Cohn

Eur J Heart Fail· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, Aldo Clerico, Roberto Latini, Jay N Cohn

Eur J Prev Cardiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, Andrea Ripoli, Roberto Latini, Jay N Cohn

Int J Cardiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Antoni Bayes-Genis, Josep Lupón, Jay N Cohn

J Am Coll Cardiol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Disease Progression: A Target for Therapy?
Jay N Cohn

Am J Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.
Kay-Won Chang, Neil Beri, Nghia H Nguyen, Boris Arbit, Sutton Fox, Jay N Cohn

J Card Fail· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Franco Cosmi, Li Shen, Michela Magnoli, William T Abraham, Inder S Anand, Jay N Cohn

Eur J Heart Fail· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MY APPROACH to the patient with heart failure and improved ejection fraction.
Jay N Cohn

Trends Cardiovasc Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, Andrea Ripoli, Roberto Latini, Jay N Cohn

Circulation· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study.
Daniel A Duprez, Natalia Florea, Sue Duval, Catherine Koukol, Jay N Cohn

J Hum Hypertens· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study.
Kevin F Boreskie, D Scott Kehler, Eduardo C Costa, Pedro C Cortez, Ivan Berkowitz, Jay N Cohn

BMJ Open· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Paradox in Demonstrating Hydralazine-Nitrate Efficacy.
Jay N Cohn

JACC Heart Fail· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Office Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment.
Jay N Cohn, Daniel A Duprez, Lynn Hoke, Natalia Florea, Sue Duval

Hypertension· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
Viorel G Florea, Thomas S Rector, Inder S Anand, Jay N Cohn

Circ Heart Fail· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials: Heart failure treatment - clinical trials versus clinical practice.
Jay N Cohn

Nat Rev Cardiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slowing the Progression of Cardiovascular Disease.
Jay N Cohn

J Am Coll Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trials and Tribulations.
Jay N Cohn

J Card Fail· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of cardiovascular disease.
Jay N Cohn

Trends Cardiovasc Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
Patrick Rossignol, Serge Masson, Simona Barlera, Nicolas Girerd, Angelo Castelnovo, Jay N Cohn

Eur J Heart Fail· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis